|
See related BeneFIX powd for inj information |
|
|
|
Manufacturer |
Pfizer |
|
Distributor |
Hong Kong: Zuellig/Macau: LF Asia (Macao) |
|
Contents |
Nonacog α |
|
Indications |
Control & prevention of haemorrhagic episodes in patients w/ haemophilia B (congenital factor IX deficiency or Christmas disease) including bleeding in surgical settings.
Click to view BeneFIX detailed prescribing infomation |
|
Dosage |
Individualised dosage. Minor haemorrhage (uncomplicated haemarthroses, superficial muscular or soft tissue) 20-30 IU/dL for 1-2 days. Moderate haemorrhage (intramuscle or soft tissue w/ dissection, mucous membranes, dental extractions, haematuria) 25-50 IU/dL for 2-7 days. Major haemorrhage (pharynx, retropharynx, retroperitoneum, CNS, surgery) 50-100 IU/dL for 7-10 days. All doses to be taken every 12-24 hr.
Click to view BeneFIX detailed prescribing infomation |
|
Overdosage |
View BeneFIX overdosage for action to be taken in the event of an overdose. |
|
Contraindications |
History of allergic reaction to hamster protein.
Click to view BeneFIX detailed prescribing infomation |
|
Special Precautions |
Potential risk of thrombosis & disseminated intravascular coagulation. Liver disease, post-op patients, fibrinolysis, those at risk of thromboembolic phenomena. Monitor for the development of factor IX inhibitors. Discontinue if hypersensitivity reactions occur. Pregnancy & lactation. Childn.
Click to view BeneFIX detailed prescribing infomation |
|
Adverse Drug Reactions |
Nausea, altered taste, dizziness, headache, cough w/ hypoxaemia, discomfort at IV site.
View ADR Monitoring Form |
|
Drug Interactions |
[Click for BeneFIX detailed prescribing infomation]
View more drug interactions with BeneFIX |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Caution For Usage |
For caution against possible variation of physical aspect of medicine... click to view BeneFIX detailed prescribing infomation |
|
Storage |
View BeneFIX storage conditions for details to ensure optimal shelf-life. |
|
Description |
View BeneFIX description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View BeneFIX mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
ATC Classification |
B02BD09 - nonacog alfa ; Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
BeneFIX powder for injection |
|
|
|
Manufacturer: |
Pfizer |
|
Distributor: |
Hong Kong: Zuellig
Macau: LF Asia (Macao) |
|
|
|
